Ramón
García Sanz
University Hospital Brno
Brno, República ChecaUniversity Hospital Brno-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2020
-
A phase 2 study of ibrutinib in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma
European Journal of Haematology, Vol. 104, Núm. 5, pp. 435-442